4/A//SEC Filing
ProPhase Labs, Inc. 4/A
Accession 0001493152-15-006113
$PRPHCIK 0000868278operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 11:27 AM ET
Size
7.0 KB
Accession
0001493152-15-006113
Insider Transaction Report
Form 4/AAmended
Leventhal Mark S
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0005
2015-11-25$1.30/sh+17,252$22,428→ 867,732 total - Purchase
Common Stock, par value $0.0005
2015-11-24$1.30/sh+18,500$24,050→ 850,480 total
Footnotes (3)
- [F1]This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 25, 2015.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000868278
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 11:27 AM ET
- Size
- 7.0 KB